clonidine hydrochloride · Azurity · NDA 220256
Javadin
Earliest generic entry, as listed
15 Jul 2042
Blocked by patent: US 12233049, US 12440474, US 12721837.
Listed patents · 3 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12233049 | product | 15 Jul 2042 |
| US 12440474 | product | 15 Jul 2042 |
| US 12721837 | product | 15 Jul 2042 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 220256 · 001 · RLD | solution, oral | 0.02MG/ML | 15 Jul 2042 |